Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine PK and Sedation in Tympanoplasty
NCT03800641Phase 4Completed
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in anxiety disorder and emergence delirium (ED), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Dexmedetomidine Pharmacokinetic Curve. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorderemergence delirium (ED)
Beyond the preview
Go deeper on NCT03800641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800641.